Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching from Lamivudine to Clevudine in Chronic Hepatitis B
NCT00558493Phase 4Completed
- Sponsor
- Bukwang Pharmaceutical
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by Bukwang Pharmaceutical. Started Nov 2007; status: completed.
02
Drugs
clevudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00558493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558493.